Needham Maintains Buy on Dentsply Sirona, Lowers Price Target to $29
Portfolio Pulse from Benzinga Newsdesk
Needham analyst David Saxon maintains a Buy rating on Dentsply Sirona (NASDAQ:XRAY) but lowers the price target from $34 to $29.

October 28, 2024 | 11:54 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst David Saxon maintains a Buy rating on Dentsply Sirona but lowers the price target from $34 to $29, indicating a more cautious outlook.
The maintenance of a Buy rating suggests continued confidence in the stock, but the lowered price target indicates a more cautious outlook, likely due to revised expectations or market conditions. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100